Trefoil factor 3 is oncogenic and mediates anti-estrogen resistance in human mammary carcinoma

Trefoil factor 3 is oncogenic and mediates anti-estrogen resistance in human mammary carcinoma

10.1593/neo.10916

Saved in:

Bibliographic Details
Main Authors:	Kannan, N., Kang, I., Kong, X., Tang, J., Perry, J.K., Mohankumar, K.M., Miller, L.D., Liu, E.T., Mertani, H.C., Zhu, T., Grandison, P.M., Liu, D.-X., Lobie, P.E.
Other Authors:	CANCER SCIENCE INSTITUTE OF SINGAPORE
Format:	Article
Published:	2014
Online Access:	http://scholarbank.nus.edu.sg/handle/10635/116661
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

Similar Items

The prolactin receptor mediates HOXA1-stimulated oncogenicity in mammary carcinoma cells
by: Hou, L., et al.
Published: (2014)

Oncogenic transformation of human mammary epithelial cells by autocrine human growth hormone
by: Zhu, T., et al.
Published: (2014)

Human growth hormone-regulated HOXA1 is a human mammary epithelial oncogene
by: Zhang, X., et al.
Published: (2014)

SHON is a novel estrogen-regulated oncogene in mammary carcinoma that predicts patient response to endocrine therapy
by: Jung, Y., et al.
Published: (2014)

Trefoil factor 3 promotes metastatic seeding and predicts poor survival outcome of patients with mammary carcinoma
by: Pandey, V, et al.
Published: (2020)

THE ROLE OF TREFOIL FACTOR 3 IN MAMMARY CARCINOMA ANGIOGENESIS
by: LAU WAI HOE
Published: (2015)

Trefoil factor 3 mediation of oncogenicity and chemoresistance in hepatocellular carcinoma is AKT-BCL-2 dependent
by: You, M.-L, et al.
Published: (2020)

Trefoil factor-3 (TFF3) stimulates de novo angiogenesis in mammary carcinoma both directly and indirectly via IL-8/CXCR2
by: Lau W.-H., et al.
Published: (2018)

Hypomethylation associated enhanced transcription of trefoil factor-3 mediates tamoxifen-stimulated oncogenicity of ER+ endometrial carcinoma cells
by: Pandey, V, et al.
Published: (2020)

Trefoil factor 1 suppression of E-CADHERIN enhances prostate carcinoma cell invasiveness and metastasis
by: Bougen, N.M., et al.
Published: (2014)

Release of HER2 repression of trefoil factor 3 (TFF3) expression mediates trastuzumab resistance in HER2+/ER+ mammary carcinoma
by: Chong, Q.-Y, et al.
Published: (2020)

Expression of two non-mutated genetic elements is sufficient to stimulate oncogenic transformation of human mammary epithelial cells
by: Pandey, V, et al.
Published: (2020)

STAT3α is oncogenic for endometrial carcinoma cells and mediates the oncogenic effects of autocrine human growth hormone
by: Tang, J.-Z., et al.
Published: (2014)

Autocrine human growth hormone reduces mammary and endometrial carcinoma cell sensitivity to mitomycin C
by: Bougen, N.M., et al.
Published: (2014)

Tumor expression of human growth hormone and human prolactin predict a worse survival outcome in patients with mammary or endometrial carcinoma
by: Wu, Z.-S., et al.
Published: (2014)

Phenotypic conversion of human mammary carcinoma cells by autocrine human growth hormone
by: Mukhina, S., et al.
Published: (2016)

Autocrine human growth hormone (hGH) regulation of human mammary carcinoma cell gene expression. Identification of CHOP as a mediator of hGH-stimulated human mammary carcinoma cell survival
by: Mertani, H.C., et al.
Published: (2014)

THE ONCOGENIC ROLE OF TREFOIL FACTOR 3 (TFF3) IN NON-SMALL CELL LUNG CANCER (NSCLC)
by: ZHANG MENGYI
Published: (2019)

Autocrine stimulation of human mammary carcinoma cell proliferation by human growth hormone
by: Kaulsay, K.K., et al.
Published: (2014)

Autocrine human GH promotes radioresistance in mammary and endometrial carcinoma cells
by: Bougen, N.M., et al.
Published: (2014)

High stromal and epithelial human GH gene expression is associated with proliferative disorders of the mammary gland
by: Raccurt, M., et al.
Published: (2014)

Inhibition of TFF3 enhances sensitivity—and overcomes acquired resistance—to doxorubicin in estrogen receptor-positive mammary carcinoma
by: Poh, H.M., et al.
Published: (2021)

HOXA1 is required for E-cadherin-dependent anchorage-independent survival of human mammary carcinoma cells
by: Zhang, X., et al.
Published: (2016)

Characterizing neutrophil response to estrogen during mammary involution
by: Ong, Zoe
Published: (2017)

ARTEMIN Promotes De Novo Angiogenesis in ER Negative Mammary Carcinoma through Activation of TWIST1-VEGF-A Signalling
by: Banerjee, A., et al.
Published: (2014)

p44/42 MAP kinase-dependent regulation of catalase by autocrine human growth hormone protects human mammary carcinoma cells from oxidative stress-induced apoptosis
by: Zhu, Z., et al.
Published: (2016)

ARTEMIN synergizes with TWIST1 to promote metastasis and poor survival outcome in patients with ER negative mammary carcinoma
by: Banerjee, A., et al.
Published: (2014)

Immunohistochemical Determination of Estrogen and Progesterone Receptors in Canine Mammary Tumors
by: Warapan Toniti, et al.
Published: (2018)

Estrogen exacerbates mammary involution through neutrophil-dependent and -independent mechanism
by: Lim, Chew Leng, et al.
Published: (2020)

Estrogen exacerbates mammary involution through neutrophil-dependent and -independent mechanism
by: Lim, Chew Leng, et al.
Published: (2020)

Estrogen exacerbates mammary involution through neutrophil-dependent and -independent mechanism
by: Lim, Chew Leng, et al.
Published: (2020)

The trefoil factor 1 (TFF1) protein involved in doxorubicin-induced apoptosis resistance is upregulated by estrogen in breast cancer cells
by: Sonam Pelden, et al.
Published: (2018)

Artemin stimulates radio- and chemo-resistance by promoting TWIST1-BCL-2-dependent cancer stem cell-like behavior in mammary carcinoma cells
by: Banerjee, A., et al.
Published: (2014)

Estrogen regulation of mammary involution and its implication in Parity Associated Breast Cancer
by: Lim, Chew Leng
Published: (2020)

Estrogen reprograms the activity of neutrophils to foster protumoral microenvironment during mammary involution
by: Chung, Hwa Hwa, et al.
Published: (2018)

Autocrine proliferative effects of hGH are maintained in primary cultures of human mammary carcinoma cells
by: Chiesa, J., et al.
Published: (2014)

Autocrine human growth hormone inhibits placental transforming growth factor-β gene transcription to prevent apoptosis and allow cell cycle progression of human mammary carcinoma cells
by: Graichen, R., et al.
Published: (2014)

Artemin is hypoxia responsive and promotes oncogenicity and increased tumor initiating capacity in hepatocellular carcinoma
by: Zhang, M, et al.
Published: (2020)

Growth hormone and cancer: An update on progress
by: Perry, J.K., et al.
Published: (2014)

Coherently tunable triangular trefoil phaseonium metamaterial
by: Soci, Cesare, et al.
Published: (2018)